Table 1. Correlation of clinicopathologic variables with THOP1 protein in NSCLC.
Category | No. of patients | THOP1 | ||
high | low | P a | ||
Age | 0.539 | |||
<60 years | 67 | 29 | 38 | |
≥60 years | 53 | 20 | 33 | |
Sex | 0.611 | |||
Male | 67 | 26 | 41 | |
Female | 53 | 23 | 30 | |
Smoking history | 0.300 | |||
Yes | 52 | 24 | 28 | |
No | 68 | 25 | 43 | |
Histology | 0.826 | |||
SCC | 70 | 28 | 42 | |
Adeno | 50 | 21 | 29 | |
Differentiation | 0.247 | |||
Well | 31 | 8 | 23 | |
Moderate | 58 | 24 | 34 | |
Poor | 31 | 17 | 14 | |
Tumor size | 0.117 | |||
≤3 cm | 51 | 25 | 26 | |
>3 cm | 69 | 24 | 45 | |
Lymph node metastasis | 0.048 | |||
N0 | 60 | 29 | 29 | |
N1, N2 | 73 | 20 | 42 | |
TNM stage | 0.491 | |||
Stage I | 47 | 21 | 26 | |
Stage II and III | 73 | 28 | 45 |
Chi-square test.
SCC squamous cell cancer.
Adeno adenocarcinoma.